Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells

被引:141
作者
Marshall, JS [1 ]
LealBerumen, I [1 ]
Nielsen, L [1 ]
Glibetic, M [1 ]
Jordana, M [1 ]
机构
[1] MCMASTER UNIV,INTESTINAL DIS RES PROGRAMME,HLTH SCI CTR,HAMILTON,ON L8N 3Z5,CANADA
关键词
mast cells; IL-10; IL-6; TNF-alpha; inflammation;
D O I
10.1172/JCI118506
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Mast cells have been implicated in a number of diseases involving chronic inflammation including asthma, rheumatoid arthritis, and inflammatory bowel diseases. They are a potent source of several cytokines, including IL-6 and TNF-alpha. Freshly isolated rat peritoneal mast cells will produce IL-6 in response to anti-IgE, LPS, PGE(1), or PGE(2); however, the mechanisms by which such cytokine production is regulated are poorly understood. IL-10 is recognized as an important immunoregulatory cytokine with effects on T cell development and the production of inflammatory cytokines. IL-10 has previously been described to enhance mast cell development in the context of IL-3 and IL-4. In the current study, we have examined the ability of IL-10 to modulate rat peritoneal mast cell IL-6 and TNF-alpha production in response to a variety of stimuli. We have observed that recombinant murine IL-10 can inhibit the production of both IL-6 and TNF-alpha by mast cells without altering the degree of histamine release in response to anti-IgE. Concentrations of IL-10 as low as 0.2 ng/ml were sufficient to inhibit IL-6 production by LPS- or anti-IgE-activated cells significantly. IL-10 also inhibited PGE(1)- and PGE(2)-induced IL-6 production. The relative potency of IL-10 as an inhibitor of mast cell IL-6 production was highly dependent upon the stimulus used, with a 10-fold difference in the IC50 for LPS- or anti-IgE-activated cells (0.21 ng/ml) and cells activated with a combination of LPS and PGE, (2.29 ng/ml). This suggests that prostanoids may limit the ability of IL-10 to modulate mast cell IL-6 production in the context of inflammation. These data have important implications for the regulation of mast cell IL-6 in inflammatory diseases involving prostanoid production and the effects of treatment with cyclooxygenase inhibitors. Our results also demonstrate a dual role for IL-10 on mast cells as a growth factor and inhibitor of cytokine production.
引用
收藏
页码:1122 / 1128
页数:7
相关论文
共 45 条
  • [11] 2 TYPES OF MOUSE T-HELPER CELL .4. TH2 CLONES SECRETE A FACTOR THAT INHIBITS CYTOKINE PRODUCTION BY TH1 CLONES
    FIORENTINO, DF
    BOND, MW
    MOSMANN, TR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (06) : 2081 - 2095
  • [12] FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
  • [13] GALLI SJ, 1988, AM J PATHOL, V128, P131
  • [14] INTERFERON BETA-2/B-CELL STIMULATORY FACTOR TYPE-2 SHARES IDENTITY WITH MONOCYTE-DERIVED HEPATOCYTE-STIMULATING FACTOR AND REGULATES THE MAJOR ACUTE PHASE PROTEIN RESPONSE IN LIVER-CELLS
    GAULDIE, J
    RICHARDS, C
    HARNISH, D
    LANSDORP, P
    BAUMANN, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (20) : 7251 - 7255
  • [15] INTERLEUKIN-10 REDUCES THE RELEASE OF TUMOR-NECROSIS-FACTOR AND PREVENTS LETHALITY IN EXPERIMENTAL ENDOTOXEMIA
    GERARD, C
    BRUYNS, C
    MARCHANT, A
    ABRAMOWICZ, D
    VANDENABEELE, P
    DELVAUX, A
    FIERS, W
    GOLDMAN, M
    VELU, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) : 547 - 550
  • [16] INTERLEUKIN-10 PRODUCTION CORRELATES WITH PATHOLOGY IN HUMAN LEISHMANIA-DONOVANI INFECTIONS
    GHALIB, HW
    PIUVEZAM, MR
    SKEIKY, YAW
    SIDDIG, M
    HASHIM, FA
    ELHASSAN, AM
    RUSSO, DM
    REED, SG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (01) : 324 - 329
  • [17] MAST-CELLS AS A SOURCE OF BOTH PREFORMED AND IMMUNOLOGICALLY INDUCIBLE TNF-ALPHA CACHECTIN
    GORDON, JR
    GALLI, SJ
    [J]. NATURE, 1990, 346 (6281) : 274 - 276
  • [18] GRUBER BL, 1988, J IMMUNOL, V140, P3936
  • [19] PRODUCTION OF INTERFERON-GAMMA, INTERLEUKIN-2, INTERLEUKIN-4, AND INTERLEUKIN-10 BY CD4+ LYMPHOCYTES INVIVO DURING HEALING AND PROGRESSIVE MURINE LEISHMANIASIS
    HEINZEL, FP
    SADICK, MD
    MUTHA, SS
    LOCKSLEY, RM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) : 7011 - 7015
  • [20] HOAGABOAM CM, 1993, GASTROENTEROLOGY, V104, P122